Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jie Ying Chan"'
All supplemental figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7fdbafde967165affc1283240531a7d
https://doi.org/10.1158/1535-7163.22504326.v1
https://doi.org/10.1158/1535-7163.22504326.v1
Publikováno v:
Oncogene
The insulin-like growth factor (IGF) system is a well-studied growth regulatory pathway implicated in breast cancer biology. Clinical trials testing monoclonal antibodies directed against the type I IGF receptor (IGF1R) in combination with estrogen r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b511f0fb103e1407f1bd8fdbdeb2e51
https://doi.org/10.1038/onc.2015.488
https://doi.org/10.1038/onc.2015.488
Publikováno v:
Hormonescancer. 9(6)
Insulin and insulin-like growth factor (IGF) signaling systems regulate breast cancer growth, progression, and metastasis. The insulin receptor substrates 1 and 2 (IRS1/2) transduce signaling from the type I IGF receptor (IGF-IR) and insulin receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4213887d9e81a26c2e73b6a10964546
https://pubmed.ncbi.nlm.nih.gov/30229539
https://pubmed.ncbi.nlm.nih.gov/30229539
Publikováno v:
Cancer Research. 75:P4-06
Selective estrogen receptor modulators (SERMs) such as tamoxifen have been a conventional therapy for breast cancer patients expressing estrogen receptor, representing the most common breast cancer type. The development of secondary resistance to SER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cd550129bfb52aff7a68bb2bb62a2d8
https://doi.org/10.1158/1538-7445.sabcs14-p4-06-02
https://doi.org/10.1158/1538-7445.sabcs14-p4-06-02
Publikováno v:
Molecular cancer therapeutics. 16(7)
Insulin receptor (InsR) and the type I insulin-like growth factor (IGF1R) are homologous receptors necessary for signal transduction by their cognate ligands insulin, IGF-I and IGF-II. IGF1R mAbs, intended to inhibit malignant phenotypic signaling, f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50979701c9d524572f0ade28610f4116
https://pubmed.ncbi.nlm.nih.gov/28468775
https://pubmed.ncbi.nlm.nih.gov/28468775
Publikováno v:
The Journal of Physical Chemistry C. 113:10446-10451
Nanoscale-driven design of electron emission materials can significantly increase their overall efficiency as cathodes for field-induced electron emission by taking advantage of the field enhancement effect. The refractory nature and low work functio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::debe73c9cfc43a8ae32400294ddfca7b
https://doi.org/10.1021/jp901717h
https://doi.org/10.1021/jp901717h
Publikováno v:
Cancer Research. 76:1881-1881
Selective estrogen receptor modulators (SERMs) such as tamoxifen are used to treat estrogen receptor (ER) positive breast cancers, the most common intrinsic subtype. The development of secondary resistance to SERMs is an unsolved clinical dilemma, le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24be0417312a84dd3a72c41f21934f54
https://doi.org/10.1158/1538-7445.am2016-1881
https://doi.org/10.1158/1538-7445.am2016-1881
Autor:
Yuzhe Yang, Dedra H. Fagan, Heather Beckwith, Aleksandra M. Ochnik, Jie Ying Chan, Xihong Zhang, Douglas Yee, Lynsey Fettig Anderson, Kelly LaPara
Publikováno v:
Molecular Cancer Research. 11:IA17-IA17
Transmembrane growth factor receptors mediate signaling through multiple intracellular pathways. In breast cancer cells, the type I insulin-like growth factor receptor (IGF1R) has been implicated in the malignant phenotype. However, clinical trials w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c487015de559761e586eed6c950f0729
https://doi.org/10.1158/1557-3125.advbc-ia17
https://doi.org/10.1158/1557-3125.advbc-ia17